Source:http://linkedlifedata.com/resource/pubmed/id/20224412
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-4-15
|
pubmed:abstractText |
Pelvic lymph node dissection in patients with clinically localized prostate cancer has long been an established part of radical prostatectomy that provides prognostic information in men with locally metastatic disease. However, given downward stage migration over the last 25 years, it is no longer clear that pelvic lymphadenectomy is pertinent for most men diagnosed today. In men in whom it is pertinent, it is unclear how extensive a lymphadenectomy should be performed.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1473-6586
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
211-7
|
pubmed:meshHeading |
pubmed-meshheading:20224412-Humans,
pubmed-meshheading:20224412-Lymph Node Excision,
pubmed-meshheading:20224412-Lymphatic Metastasis,
pubmed-meshheading:20224412-Male,
pubmed-meshheading:20224412-Prognosis,
pubmed-meshheading:20224412-Prostatectomy,
pubmed-meshheading:20224412-Prostatic Neoplasms,
pubmed-meshheading:20224412-Risk Factors
|
pubmed:year |
2010
|
pubmed:articleTitle |
Pelvic node dissection in prostate cancer: extended, limited, or not at all?
|
pubmed:affiliation |
The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Review,
Research Support, N.I.H., Extramural
|